NPPA outcome data
The data on this page relates to initial applications received in last four financial years.
2021–2025 data
The table below gives the number of initial applications and the result of the application by chemical for the last four financial years (1 July to 30 June). The Excel spreadsheet download provides indications (by chemical), where providing this information will not impact anyone's privacy.
If you have questions about a specific chemical or indication, email nppa@pharmac.govt.nz
Summary of all applications
| Outcome | Number of applications |
|---|---|
| Approved | 3397 |
| Declined | 17 |
| Principles not met | 1256 |
| Withdrawn | 493 |
| Grand Total | 5162 |
Summary of outcome by chemical type
The number of applications in this table is less than the summary total. We have removed the applications where the information could lead to identifying someone.
Outcome by chemical and indication [XLSX, 94 KB]
Looking for a specific chemical? Using a keyboard, you can use the browser's inbuilt search by typing ctrl+f (or cmd+f)
| Chemical | Approved | Declined | Principles not met | Withdrawn | Grand Total |
|---|---|---|---|---|---|
| adalimumab | 32 | 14 | 14 | 60 | |
| alirocumab | 2 | 6 | 2 | 10 | |
| alitretinoin | 1 | 7 | 8 | ||
| alpha tocopheryl acetate | 220 | 2 | 4 | 226 | |
| amino acid formula (without isoleucine, leucine and valine) | 8 | 8 | |||
| amino acid formula low calcium | 12 | 12 | |||
| anakinra | 32 | 8 | 5 | 45 | |
| apixaban | 8 | 1 | 9 | ||
| aprepitant | 22 | 3 | 2 | 27 | |
| asciminib | 6 | 1 | 7 | ||
| atezolizumab | 1 | 1 | 14 | 1 | 17 |
| azacitidine | 27 | 3 | 1 | 31 | |
| azithromycin | 2 | 4 | 3 | 9 | |
| bedaquiline | 31 | 3 | 34 | ||
| bevacizumab | 33 | 10 | 2 | 45 | |
| biotin | 13 | 13 | |||
| bortezomib | 21 | 2 | 23 | ||
| brentuximab vedotin | 34 | 6 | 1 | 41 | |
| cabozantinib | 5 | 1 | 1 | 7 | |
| cannabinoid | 9 | 35 | 3 | 47 | |
| cefiderocol | 9 | 9 | |||
| ceftazidime and avibactam | 8 | 2 | 10 | ||
| ciclosporin eye preparations | 255 | 8 | 2 | 265 | |
| cinacalcet | 3 | 7 | 4 | 14 | |
| continuous glucose monitor | 27 | 21 | 3 | 51 | |
| dabrafenib | 12 | 5 | 1 | 18 | |
| danazol | 8 | 1 | 9 | ||
| daratumumab | 3 | 5 | 8 | ||
| deferasirox | 6 | 4 | 4 | 14 | |
| deferiprone | 7 | 1 | 8 | ||
| denosumab | 19 | 22 | 2 | 43 | |
| dipyridamole | 13 | 13 | |||
| dulaglutide | 5 | 19 | 6 | 30 | |
| dupilumab | 19 | 19 | 7 | 45 | |
| eculizumab | 11 | 1 | 11 | 3 | 26 |
| elexacaftor/tezacaftor/ivacaftor | 4 | 3 | 1 | 8 | |
| eltrombopag | 15 | 9 | 4 | 28 | |
| emicizumab | 5 | 8 | 13 | ||
| empagliflozin | 2 | 15 | 1 | 18 | |
| enoxaparin sodium | 20 | 6 | 26 | ||
| epoetin alfa | 6 | 1 | 3 | 10 | |
| erlotinib | 9 | 9 | |||
| etanercept | 14 | 3 | 5 | 22 | |
| everolimus | 10 | 3 | 1 | 14 | |
| fluoxetine | 3 | 3 | 1 | 7 | |
| galcanezumab | 4 | 11 | 15 | ||
| ganciclovir eye preparations | 16 | 1 | 17 | ||
| gemtuzumab | 8 | 2 | 10 | ||
| ibrutinib | 5 | 15 | 20 | ||
| idebenone | 8 | 8 | |||
| indomethacin | 22 | 1 | 23 | ||
| infliximab | 50 | 15 | 2 | 67 | |
| insulin pump | 4 | 1 | 2 | 7 | |
| insulin pump consumables | 3 | 3 | 6 | ||
| ipilimumab | 4 | 1 | 2 | 7 | |
| isavuconazole | 7 | 2 | 9 | ||
| ivabradine | 9 | 9 | 1 | 19 | |
| ketamine | 40 | 2 | 42 | ||
| ketotifen | 5 | 2 | 7 | ||
| lacosamide | 7 | 2 | 9 | ||
| lamotrigine | 57 | 29 | 5 | 91 | |
| l-asparaginase | 11 | 11 | |||
| lenalidomide | 24 | 4 | 1 | 29 | |
| lenvatinib | 2 | 4 | 1 | 7 | |
| letermovir | 11 | 3 | 1 | 15 | |
| levetiracetam | 56 | 1 | 4 | 61 | |
| levocarnitine | 5 | 3 | 1 | 9 | |
| levofloxacin | 13 | 4 | 17 | ||
| linezolid | 25 | 1 | 3 | 29 | |
| liraglutide | 2 | 35 | 37 | ||
| macitentan | 13 | 5 | 1 | 19 | |
| mavacamten | 6 | 1 | 7 | ||
| melatonin | 2 | 10 | 1 | 13 | |
| meningococcal (a, c, y and w-135) conjugate vaccine | 8 | 1 | 9 | ||
| mepolizumab | 10 | 6 | 16 | ||
| midostaurin | 6 | 1 | 3 | 10 | |
| minocycline | 8 | 8 | |||
| mitotane | 24 | 24 | |||
| moxifloxacin | 23 | 3 | 3 | 29 | |
| mycophenolic acid | 4 | 1 | 2 | 7 | |
| naltrexone hydrochloride | 6 | 1 | 7 | ||
| nelarabine | 12 | 2 | 14 | ||
| nilotinib | 6 | 1 | 7 | ||
| nintedanib | 1 | 7 | 2 | 10 | |
| nirmatrelvir with ritonavir | 1 | 3 | 6 | 10 | |
| nivolumab | 9 | 8 | 1 | 18 | |
| obinutuzumab | 6 | 6 | 1 | 13 | |
| octreotide | 8 | 7 | 3 | 18 | |
| olaparib | 16 | 8 | 24 | ||
| omalizumab | 14 | 3 | 2 | 19 | |
| oral feed liquid | 6 | 8 | 2 | 16 | |
| oral feed paediatric renal | 7 | 7 | |||
| palivizumab | 1 | 12 | 5 | 18 | |
| pazopanib | 14 | 7 | 1 | 22 | |
| pegylated inteferon alpha-2a | 9 | 1 | 2 | 12 | |
| pegylated liposomal doxorubicin hydrochloride | 4 | 9 | 13 | ||
| pembrolizumab | 29 | 28 | 2 | 59 | |
| perampanel | 9 | 7 | 9 | 25 | |
| ponatinib | 11 | 2 | 13 | ||
| posaconazole | 30 | 1 | 2 | 33 | |
| potassium citrate | 6 | 3 | 1 | 10 | |
| pretomanid | 13 | 13 | |||
| pristinamycin | 24 | 24 | |||
| prucalopride | 21 | 21 | 3 | 45 | |
| regorafenib | 10 | 10 | |||
| retinol (vitamin a) | 236 | 7 | 2 | 245 | |
| ribavirin | 6 | 2 | 8 | ||
| rifaximin | 1 | 9 | 10 | ||
| rituximab | 160 | 44 | 18 | 222 | |
| roxadustat | 10 | 10 | |||
| rufinamide | 39 | 1 | 40 | ||
| ruxolitinib | 32 | 10 | 3 | 45 | |
| secukinumab | 18 | 11 | 2 | 31 | |
| selexipag | 8 | 7 | 15 | ||
| sirolimus | 25 | 3 | 1 | 29 | |
| sirolimus ointment | 13 | 1 | 14 | ||
| sodium chloride | 3 | 12 | 1 | 16 | |
| sodium dl-3-hydroxybutyrate | 7 | 7 | |||
| sorafenib | 11 | 1 | 12 | ||
| stanozolol | 12 | 1 | 13 | ||
| sunitinib | 8 | 4 | 2 | 14 | |
| tacrolimus | 11 | 3 | 3 | 17 | |
| tacrolimus ointment | 4 | 1 | 4 | 9 | |
| tadalafil | 14 | 7 | 1 | 22 | |
| taurolidine and citrate | 4 | 3 | 7 | ||
| teriparatide | 4 | 5 | 3 | 12 | |
| thalidomide | 15 | 2 | 17 | ||
| tinidazole | 14 | 14 | |||
| tobramycin | 2 | 9 | 3 | 14 | |
| tocilizumab | 98 | 21 | 11 | 130 | |
| tofacitinib | 8 | 3 | 1 | 12 | |
| trametinib | 13 | 10 | 1 | 24 | |
| upadacitinib | 43 | 38 | 5 | 86 | |
| ursodeoxycholic acid | 3 | 3 | 3 | 9 | |
| ustekinumab | 5 | 16 | 2 | 23 | |
| valganciclovir | 21 | 21 | |||
| varicella zoster vaccine | 12 | 9 | 21 | ||
| vedolizumab | 2 | 4 | 1 | 7 | |
| venetoclax | 17 | 20 | 1 | 38 | |
| venlafaxine | 1 | 4 | 2 | 7 | |
| vinorelbine | 7 | 7 | |||
| voriconazole | 20 | 1 | 21 | ||
| zonisamide | 56 | 4 | 60 | ||
| Grand Total | 2718 | 8 | 894 | 260 | 3880 |